Kazumi Shiosaki

Parallel synthesis of 3-aminoimidazo[1,2-a]pyridines and pyrazines by a new three-component condensation

Christopher Blackburn, Bing Guan, Paul Fleming et al. · Tetrahedron Letters · 1998 · 371 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

.alpha.-Amino acids as chiral educts for asymmetric products. Chirospecific syntheses of the 5-butyl-2-heptylpyrrolidines from glutamic acid

Kazumi Shiosaki, Henry Rapoport · The Journal of Organic Chemistry · 1985 · 101 citations

Natural Sciences, Biochemistry, Chemistry +11

Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and β-Amyloid Toxicity in Human Neuronal Cell Line

Yong Shen, Rena Li, Kazumi Shiosaki · Journal of Biological Chemistry · 1997 · 98 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Kazumi Shiosaki, Peter Jenner, Karen E. Asin et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 63 citations

Medicine, Medicinal Chemistry, Pharmacology +17

(5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)

Michael R. Michaelides, Yufeng Hong, Stanley DiDomenico et al. · Journal of Medicinal Chemistry · 1995 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12